Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Theta Burst Stimulation for Schizophrenia
Theta Burst Stimulation for Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Theta Burst Stimulation for Schizophrenia
Theta Burst Stimulation for Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
A Pilot Open-label Trial of Pentosan Polysulfate Sodium and Meclofenamic Acid As Adjunctive Treatments in Patients With Psychotic Disorders
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
A Pilot Open-label Trial of Pentosan Polysulfate Sodium and Meclofenamic Acid As Adjunctive Treatments in Patients With Psychotic Disorders
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Austin, TX
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Richardson, TX
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Richardson, TX
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Rogers, AR
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Rogers, AR
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Cerritos, CA
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Cerritos, CA
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational site
mi
from
Culver City, CA
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational site
mi
from
Culver City, CA
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Lemon Grove, CA
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Hialeah, FL
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Berlin, NJ
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Las Vegas, NV
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Garland, TX
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Garland, TX
Click here to add this to my saved trials
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Flowood, MS
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia in Subjects Hospitalized for Acute Exacerbation
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Flowood, MS
Click here to add this to my saved trials
Examining Persistence in Smokers With Schizophrenia
Examining Persistence in Smokers With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Rutgers Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Examining Persistence in Smokers With Schizophrenia
Examining Persistence in Smokers With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Rutgers Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Kashinath Yadalam
mi
from
Lake Charles, LA
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Kashinath Yadalam
mi
from
Lake Charles, LA
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Pillar Clinical Research, LLC
mi
from
Dallas, TX
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Bugát Pál Kórház-Rendelőintézet, Rehabilitációs Elmegyógyászati Osztály
mi
from
Gyongyos,
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Bugát Pál Kórház-Rendelőintézet, Rehabilitációs Elmegyógyászati Osztály
mi
from
Gyongyos,
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Medical Research
mi
from
Atlanta, GA
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CNRI - San Diego, LLC
mi
from
San Diego, CA
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CNRI - San Diego, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research
mi
from
Austin, TX
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
A Phase 1 Randomized, 2-way, Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Cctmg/Parexel
mi
from
Glendale, CA
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
A Phase 1 Randomized, 2-way, Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Cctmg/Parexel
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
A Phase 1 Randomized, 2-way, Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research
mi
from
Austin, TX
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
A Phase 1 Randomized, 2-way, Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia: A Prospective 3-month Pilot Study
Status: Enrolling
Updated:  12/31/1969
Clinical and Translational Science Center, Weill Cornell Medicine, 525 E 68th Street, F-260
mi
from
New York, NY
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia: A Prospective 3-month Pilot Study
Status: Enrolling
Updated: 12/31/1969
Clinical and Translational Science Center, Weill Cornell Medicine, 525 E 68th Street, F-260
mi
from
New York, NY
Click here to add this to my saved trials
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated:  12/31/1969
West LA VAHCS
mi
from
Los Angeles, CA
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated: 12/31/1969
West LA VAHCS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated:  12/31/1969
University of Missouri
mi
from
Kansas City, MO
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated: 12/31/1969
University of Missouri
mi
from
Kansas City, MO
Click here to add this to my saved trials
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated:  12/31/1969
Mental Health Center of Greater Manchester
mi
from
Manchester, NH
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated: 12/31/1969
Mental Health Center of Greater Manchester
mi
from
Manchester, NH
Click here to add this to my saved trials
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated:  12/31/1969
University of South Carolina
mi
from
Columbia, SC
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Cannabis and Schizophrenia: Effects of Clozapine
Status: Enrolling
Updated: 12/31/1969
University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.
A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, 6-Week, In-Patient Study to Assess Efficacy and Safety of HP-3070 in Subjects Diagnosed With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Noven Pharmaceuticals, Inc.
mi
from
New York, NY
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.
A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, 6-Week, In-Patient Study to Assess Efficacy and Safety of HP-3070 in Subjects Diagnosed With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Noven Pharmaceuticals, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CIMU Bellflower
mi
from
Cerritos, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CIMU Bellflower
mi
from
Cerritos, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Synergy Research San Diego
mi
from
Lemon Grove, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Synergy Research San Diego
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
NRC Research Institute
mi
from
Orange, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
NRC Research Institute
mi
from
Orange, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CNRI - San Diego, LLC
mi
from
San Diego, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CNRI - San Diego, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Galiz Research
mi
from
Hialeah, FL
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Galiz Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Research, Inc.
mi
from
Hollywood, FL
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Research, Inc.
mi
from
Hollywood, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CBH Health, LLC
mi
from
Gaithersburg, MD
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CBH Health, LLC
mi
from
Gaithersburg, MD
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Precise Research Centers MS
mi
from
Flowood, MS
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Precise Research Centers MS
mi
from
Flowood, MS
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials